MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

DTI-ALPS Insights into Glymphatic Dynamics and Neurovascular Changes in Parkinson’s Disease

G. Yılmaz çakan, A. Bayram, B. Samancı, G. Kızılateş Evin, L. Karşıgil, G. Kenangil, A. Zırh, Y. Samancı (Istanbul, Turkey)

Meeting: 2026 International Congress

Keywords: Magnetic resonance imaging(MRI), Parkinson’s, Parkinsonism

Category: Parkinson's disease: Neuroimaging

Objective: To investigate glymphatic activity, structural small vessel disease (SVD) markers, and white matter microstructure in Parkinson’s disease (PD) patients, and to explore their associations with clinical and metabolic features.

Background: Glymphatic dysfunction and SVD may contribute to neurodegeneration in PD, yet their relationships with clinical and microstructural brain changes remain incompletely understood.

Method: Seventy-seven PD patients (21 female) were included. Clinical characteristics, MDS-UPDRS-III scores, and levodopa equivalent daily dose (LEDD) were recorded. Glymphatic activity was assessed using the diffusion-based ALPS index (ALPSi). Structural SVD markers included perivascular spaces (PVS) and Fazekas scores. Diffusion tensor imaging (DTI) metrics (fractional anisotropy [FA] and mean diffusivity [MD]) were analyzed across major white-matter tracts. Correlation and multivariable regression analyses were performed, with false discovery rate (FDR) correction for DTI analyses.

Results: Mean age at disease onset was 49.1 ± 10.2 years, disease duration was 9.3 ± 4.1 years, MDS-UPDRS III total score was 54.3 ± 18.8, and LEDD was 1143.5 ± 610.9 mg. Mean right and left ALPS indices were 1.41±0.18 and 1.42±0.23, without hemispheric differences. Right ALPS was independently associated with LEDD (β=0.323, p=0.004). Structural SVD markers were mainly associated with age. PVS counts and Fazekas scores correlated with age-related variables but not with most clinical features after adjustment. DTI analyses demonstrated widespread associations between age and white-matter integrity. Metabolic variables (HbA1c and fasting glucose) were also significantly associated with reduced FA and increased MD across multiple tracts after FDR correction (all p_FDR<0.05). Mean ALPS index showed a positive association with FA in the bilateral anterior thalamic radiations. No significant correlations were observed between ALPS measures and structural SVD markers.

Conclusion: Glymphatic markers, structural small vessel disease burden, and white matter microstructure appear to reflect partially distinct biological processes in PD. While vascular markers were mainly age-related, glymphatic activity correlated with microstructural integrity of the anterior thalamic radiations. These findings highlight complementary pathways of brain vulnerability in PD.

To cite this abstract in AMA style:

G. Yılmaz çakan, A. Bayram, B. Samancı, G. Kızılateş Evin, L. Karşıgil, G. Kenangil, A. Zırh, Y. Samancı. DTI-ALPS Insights into Glymphatic Dynamics and Neurovascular Changes in Parkinson’s Disease [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/dti-alps-insights-into-glymphatic-dynamics-and-neurovascular-changes-in-parkinsons-disease/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dti-alps-insights-into-glymphatic-dynamics-and-neurovascular-changes-in-parkinsons-disease/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley